Adicet Bio (ACET) News Today → Kiss of death from Joe Biden (From Porter & Company) (Ad) Free ACET Stock Alerts $1.44 -0.04 (-2.70%) (As of 03:16 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 29 at 7:00 AM | businesswire.comAdicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare ConferenceMay 22, 2024 | americanbankingnews.comFinancial Contrast: Adicet Bio (NASDAQ:ACET) and Eterna Therapeutics (NASDAQ:ERNA)May 21, 2024 | markets.businessinsider.comJMP Securities Sticks to Their Hold Rating for Adicet Bio (ACET)May 21, 2024 | americanbankingnews.comAdicet Bio (NASDAQ:ACET) Upgraded by StockNews.com to SellMay 21, 2024 | marketbeat.comAdicet Bio (NASDAQ:ACET) Upgraded to "Sell" by StockNews.comStockNews.com raised shares of Adicet Bio to a "sell" rating in a research note on Monday.May 17, 2024 | marketbeat.comQ2 2024 EPS Estimates for Adicet Bio, Inc. (NASDAQ:ACET) Decreased by AnalystAdicet Bio, Inc. (NASDAQ:ACET - Free Report) - Research analysts at Wedbush lowered their Q2 2024 EPS estimates for shares of Adicet Bio in a report released on Wednesday, May 15th. Wedbush analyst R. Driscoll now anticipates that the company will post earnings of ($0.37) per share for the quarteMay 17, 2024 | marketbeat.comAdicet Bio, Inc. (NASDAQ:ACET) Receives Average Rating of "Moderate Buy" from AnalystsShares of Adicet Bio, Inc. (NASDAQ:ACET - Get Free Report) have been given an average rating of "Moderate Buy" by the eight research firms that are presently covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and five have issued a buyMay 16, 2024 | marketbeat.comAdicet Bio, Inc. Forecasted to Earn Q1 2025 Earnings of ($0.31) Per Share (NASDAQ:ACET)Adicet Bio, Inc. (NASDAQ:ACET - Free Report) - Equities research analysts at Wedbush issued their Q1 2025 EPS estimates for Adicet Bio in a research note issued on Wednesday, May 15th. Wedbush analyst R. Driscoll anticipates that the company will post earnings of ($0.31) per share for the quarterMay 15, 2024 | marketbeat.comAdicet Bio (NASDAQ:ACET) Stock Rating Reaffirmed by WedbushWedbush reissued an "outperform" rating and set a $5.00 price target on shares of Adicet Bio in a report on Wednesday.May 14, 2024 | msn.comACET Stock Earnings: Adicet Bio Beats EPS for Q1 2024May 14, 2024 | markets.businessinsider.comAdicet Bio, Inc Q1 Loss DeclinesMay 14, 2024 | businesswire.comAdicet Reports First Quarter 2024 Financial Results and Provides Business UpdatesMay 14, 2024 | businesswire.comAdicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid CongressMay 7, 2024 | businesswire.comAdicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences ConferenceApril 30, 2024 | fool.comAdicet Bio (NASDAQ: ACET)April 30, 2024 | businesswire.comAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)April 26, 2024 | wsj.comAdicet Bio Inc.April 24, 2024 | investing.comAdicet Bio reports progress on cancer therapy ADI-270April 22, 2024 | businesswire.comAdicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual MeetingApril 10, 2024 | seekingalpha.comACET Adicet Bio, Inc.April 8, 2024 | businesswire.comAdicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual ConferenceMarch 28, 2024 | businesswire.comAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)March 28, 2024 | investorplace.comThe Penny Stock A-List: 7 High-Profile Companies on the Verge of GreatnessMarch 22, 2024 | marketbeat.comQ1 2024 Earnings Forecast for Adicet Bio, Inc. Issued By HC Wainwright (NASDAQ:ACET)Adicet Bio, Inc. (NASDAQ:ACET - Free Report) - Stock analysts at HC Wainwright lifted their Q1 2024 EPS estimates for shares of Adicet Bio in a research note issued to investors on Wednesday, March 20th. HC Wainwright analyst E. White now forecasts that the company will post earnings of ($0.43) pMarch 21, 2024 | finance.yahoo.comAdicet Bio Inc (ACET) Reports Q4 and Full Year 2023 Financial ResultsMarch 21, 2024 | finance.yahoo.comAre Investors Undervaluing Adicet Bio, Inc. (NASDAQ:ACET) By 41%?March 21, 2024 | markets.businessinsider.comAdicet Bio’s Promising Drug Pipeline and Buy Rating JustificationMarch 20, 2024 | markets.businessinsider.comBuy Recommendation for Adicet Bio Amid Promising Autoimmune and Cancer Therapy DevelopmentsMarch 20, 2024 | markets.businessinsider.comBuy Rating Affirmed for Adicet Bio Amid Promising CAR T-Cell Therapies and Strong Financial FootingMarch 20, 2024 | marketbeat.comAdicet Bio's (ACET) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $10.00 price target on shares of Adicet Bio in a research note on Wednesday.March 20, 2024 | marketbeat.comAdicet Bio (NASDAQ:ACET) Releases Quarterly Earnings Results, Beats Expectations By $0.03 EPSAdicet Bio (NASDAQ:ACET - Get Free Report) announced its earnings results on Tuesday. The company reported ($0.69) earnings per share for the quarter, beating the consensus estimate of ($0.72) by $0.03.March 20, 2024 | markets.businessinsider.comJMP Securities Keeps Their Hold Rating on Adicet Bio (ACET)March 19, 2024 | investorplace.comACET Stock Earnings: Adicet Bio Meets EPS for Q4 2023March 19, 2024 | benzinga.comAdicet Bio: Q4 Earnings InsightsMarch 19, 2024 | markets.businessinsider.comAdicet Bio, Inc Q4 loss drops in line with estimatesMarch 19, 2024 | businesswire.comAdicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company ProgressMarch 12, 2024 | marketbeat.comAdicet Bio (ACET) Set to Announce Quarterly Earnings on WednesdayAdicet Bio (NASDAQ:ACET) will be releasing earnings on Wednesday, March 13, Yahoo Finance reports.March 11, 2024 | businesswire.comAdicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual ConferenceMarch 5, 2024 | investorplace.com3 High-Risk Stocks That Could Pay Off in the MillionsMarch 1, 2024 | marketbeat.comAcadian Asset Management LLC Has $715,000 Position in Adicet Bio, Inc. (NASDAQ:ACET)Acadian Asset Management LLC increased its stake in Adicet Bio, Inc. (NASDAQ:ACET - Free Report) by 2,182.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 523,009 shares of the company's stock after purchasing anFebruary 29, 2024 | businesswire.comAdicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)February 27, 2024 | investorplace.com7 Top-Tier Penny Stocks for a Smart BetFebruary 25, 2024 | investorplace.com7 Biotech Penny Stocks on the Verge of Clinical Trial VictoryFebruary 23, 2024 | marketbeat.comAdicet Bio (NASDAQ:ACET) Share Price Passes Above Two Hundred Day Moving Average of $1.87Adicet Bio (NASDAQ:ACET) Shares Pass Above 200-Day Moving Average of $1.87February 19, 2024 | finance.yahoo.comACET Apr 2024 7.500 callFebruary 14, 2024 | marketbeat.comAdicet Bio, Inc. (NASDAQ:ACET) Sees Large Increase in Short InterestAdicet Bio, Inc. (NASDAQ:ACET - Get Free Report) saw a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 3,890,000 shares, an increase of 21.2% from the January 15th total of 3,210,000 shares. Based on an average daily volume of 1,130,000 shares, the days-to-cover ratio is presently 3.4 days.February 13, 2024 | msn.comJones upgrades Adicet to buy, cites upcoming catalystsFebruary 7, 2024 | marketbeat.comAdicet Bio, Inc. to Post Q1 2024 Earnings of ($0.28) Per Share, Wedbush Forecasts (NASDAQ:ACET)Adicet Bio, Inc. (NASDAQ:ACET - Free Report) - Wedbush increased their Q1 2024 earnings per share estimates for Adicet Bio in a research report issued on Monday, February 5th. Wedbush analyst R. Driscoll now expects that the company will post earnings per share of ($0.28) for the quarter, up fromFebruary 7, 2024 | marketbeat.comAdicet Bio, Inc. (NASDAQ:ACET) Given Average Rating of "Moderate Buy" by AnalystsAdicet Bio, Inc. (NASDAQ:ACET - Get Free Report) has been given a consensus rating of "Moderate Buy" by the seven research firms that are presently covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and four have given a buy recommendaFebruary 5, 2024 | finance.yahoo.comAdicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference Get Adicet Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ACET and its competitors with MarketBeat's FREE daily newsletter. Email Address Kiss of death from Joe Biden (Ad)In this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now. ACET Media Mentions By Week ACET Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACET News Sentiment▼0.950.82▲Average Medical News Sentiment ACET News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACET Articles This Week▼42▲ACET Articles Average Week Get Adicet Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ACET and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: WLFC News TITN News GWW News URI News FAST News WSO News WCC News AIT News BECN News AL News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACET) was last updated on 5/31/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarMissed NVDA? Buy this AI stock NOWChaikin AnalyticsGold Set to EXPLODE!Gold Safe ExchangeUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeWho are Nvidia’s New Silent Partners?Weiss RatingsDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin Pro Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adicet Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
